{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:32:51Z","timestamp":1787578371632,"version":"build-2736575974"},"reference-count":38,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T00:00:00Z","timestamp":1500249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T00:00:00Z","timestamp":1500249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["K99109667"],"award-info":[{"award-number":["K99109667"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01099076"],"award-info":[{"award-number":["R01099076"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["T32093315"],"award-info":[{"award-number":["T32093315"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Depress Anxiety"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1002\/da.22673","type":"journal-article","created":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T23:54:09Z","timestamp":1500335649000},"page":"908-917","source":"Crossref","is-referenced-by-count":32,"title":["Treatment of premenstrual dysphoria with continuous versus intermittent dosing of oral contraceptives: Results of a three-arm randomized controlled trial"],"prefix":"10.1155","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9231-3105","authenticated-orcid":false,"given":"Tory A.","family":"Eisenlohr-Moul","sequence":"first","affiliation":[{"name":"Department of Psychiatry; University of North Carolina; Chapel Hill NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan S.","family":"Girdler","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; University of North Carolina; Chapel Hill NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline L.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; University of North Carolina; Chapel Hill NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Section on Behavioral Endocrinology; NIMH IRP; Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Rubinow","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; University of North Carolina; Chapel Hill NC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,7,17]]},"reference":[{"issue":"1","key":"10.1002\/da.22673-BIB0001|da22673-cit-0001","first-page":"80","article-title":"ACOG committee opinion: Premenstrual syndrome","volume":"50","author":"American College of Obstetricians and Gynecologists Committee on Gynecologic Practice","year":"1995","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"2","key":"10.1002\/da.22673-BIB0002|da22673-cit-0002","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.wpsyc.2012.05.003","article-title":"The placebo response: Science versus ethics and the vulnerability of the patient","volume":"11","author":"Benedetti","year":"2012","journal-title":"World Psychiatry"},{"issue":"12","key":"10.1002\/da.22673-BIB0003|da22673-cit-0003","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1176\/ajp.154.12.1741","article-title":"Premenstrual syndrome: Evidence for symptom stability across cycles","volume":"154","author":"Bloch","year":"1997","journal-title":"American Journal of Psychiatry"},{"issue":"5532","key":"10.1002\/da.22673-BIB0004|da22673-cit-0004","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1126\/science.1060937","article-title":"Expectation and dopamine release: Mechanism of the placebo effect in Parkinson's Disease","volume":"293","author":"la Fuente-Fern\u00e1ndez","year":"2001","journal-title":"Science"},{"issue":"6","key":"10.1002\/da.22673-BIB0005|da22673-cit-0005","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0166-2236(02)02181-1","article-title":"The placebo effect in Parkinson's disease","volume":"25","author":"la Fuente-Fern\u00e1ndez","year":"2002","journal-title":"Trends in Neurosciences"},{"issue":"1","key":"10.1002\/da.22673-BIB0006|da22673-cit-0006","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11948-004-0071-z","article-title":"The biochemical bases of the placebo effect","volume":"10","author":"la Fuente-Fern\u00e1ndez","year":"2004","journal-title":"Science and Engineering Ethics"},{"issue":"1","key":"10.1002\/da.22673-BIB0007|da22673-cit-0007","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1176\/appi.ajp.2016.15121510","article-title":"Toward the reliable diagnosis of DSM-5 premenstrual dysphoric disorder: The Carolina Premenstrual Assessment Scoring System (C-PASS)","volume":"174","author":"Eisenlohr-Moul","year":"2017","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/da.22673-BIB0008|da22673-cit-0008","article-title":"Retrospective report of premenstrual depressive changes: Factors affecting confirmation by daily ratings","author":"Endicott","year":"1982","journal-title":"Psychopharmacology Bulletin"},{"issue":"3","key":"10.1002\/da.22673-BIB0009|da22673-cit-0009","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000069738","article-title":"The problem of the placebo response in clinical trials for psychiatric disorders: Culprits, possible remedies, and a novel study design approach","volume":"72","author":"Fava","year":"2003","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"9","key":"10.1002\/da.22673-BIB0010|da22673-cit-0010","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1176\/ajp.156.9.1403","article-title":"Characteristics of placebo responses in medical treatment of premenstrual syndrome","volume":"156","author":"Freeman","year":"1999","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/da.22673-BIB0011|da22673-cit-0011","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2011.09.010","article-title":"An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg\/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome","volume":"85","author":"Freeman","year":"2012","journal-title":"Contraception"},{"issue":"6","key":"10.1002\/da.22673-BIB0012|da22673-cit-0012","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1089\/15246090152543148","article-title":"Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder","volume":"10","author":"Freeman","year":"2001","journal-title":"Journal of Women's Health & Gender-Based Medicine"},{"issue":"2","key":"10.1002\/da.22673-BIB0013|da22673-cit-0013","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10865-005-9040-5","article-title":"Expectations and placebo response: A laboratory investigation into the role of somatic focus","volume":"29","author":"Geers","year":"2005","journal-title":"Journal of Behavioral Medicine"},{"issue":"3","key":"10.1002\/da.22673-BIB0014|da22673-cit-0014","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0022-3999(92)90090-O","article-title":"A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive","volume":"36","author":"Graham","year":"1992","journal-title":"Journal of Psychosomatic Research"},{"issue":"6","key":"10.1002\/da.22673-BIB0015|da22673-cit-0015","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1080\/0951590400018215","article-title":"The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder-Clinical procedures and research perspectives","volume":"19","author":"Halbreich","year":"2004","journal-title":"Gynecological Endocrinology"},{"issue":"07","key":"10.1002\/da.22673-BIB0016|da22673-cit-0016","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1017\/S1092852900016849","article-title":"Selective serotonin reuptake inhibitors and initial oral contraceptives for the treatment of PMDD: Effective but not enough","volume":"13","author":"Halbreich","year":"2014","journal-title":"CNS Spectrums"},{"key":"10.1002\/da.22673-BIB0017|da22673-cit-0017","first-page":"1","article-title":"The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS\/PMDD)","volume":"28","author":"Halbreich","year":"2003","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1002\/da.22673-BIB0018|da22673-cit-0018","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.contraception.2011.05.008","article-title":"Continuous oral levonorgestrel\/ethinyl estradiol for treating premenstrual dysphoric disorder","volume":"85","author":"Halbreich","year":"2012","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/da.22673-BIB0019|da22673-cit-0019","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1530\/acta.0.1250132","article-title":"Spontaneous anovulation causing disappearance of cyclical symptoms in women with the premenstrual syndrome","volume":"125","author":"Hammarb\u00e4ck","year":"1991","journal-title":"Acta Endocrinologica"},{"issue":"8","key":"10.1002\/da.22673-BIB0020|da22673-cit-0020","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archgenpsychiatry.2010.88","article-title":"Effects of expectation on placebo-induced dopamine release in Parkinson disease","volume":"67","author":"Lidstone","year":"2010","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/da.22673-BIB0021|da22673-cit-0021","first-page":"CD006586","article-title":"Oral contraceptives containing drospirenone for premenstrual syndrome","volume":"2","author":"Lopez","year":"2012","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1002\/da.22673-BIB0022|da22673-cit-0022","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.psyneuen.2016.11.033","article-title":"Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle-A double-blind, placebo-controlled randomized trial","volume":"76","author":"Lundin","year":"2017","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1002\/da.22673-BIB0023|da22673-cit-0023","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2010.10.029","article-title":"Ethinyl estradiol 20 \u03bcg\/drospirenone 3 mg 24\/4 oral contraceptive for the treatment of functional impairment in women with premenstrual dysphoric disorder","volume":"113","author":"Marr","year":"2011","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"1","key":"10.1002\/da.22673-BIB0024|da22673-cit-0024","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.contraception.2010.10.010","article-title":"Premenstrual dysphoric disorder symptom cluster improvement by cycle with the combined oral contraceptive ethinylestradiol 20 mcg plus drospirenone 3 mg administered in a 24\/4 regimen","volume":"84","author":"Marr","year":"2011","journal-title":"Contraception"},{"issue":"19","key":"10.1002\/da.22673-BIB0025|da22673-cit-0025","doi-asserted-by":"crossref","first-page":"7365","DOI":"10.1523\/JNEUROSCI.4793-14.2015","article-title":"Neural mechanisms of placebo anxiolysis","volume":"35","author":"Meyer","year":"2015","journal-title":"Journal of Neuroscience"},{"issue":"6","key":"10.1002\/da.22673-BIB0026|da22673-cit-0026","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.contraception.2005.08.021","article-title":"Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation","volume":"72","author":"Pearlstein","year":"2005","journal-title":"Contraception"},{"issue":"6","key":"10.1002\/da.22673-BIB0027|da22673-cit-0027","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.neuron.2005.05.023","article-title":"Placebo in emotional processing- Induced expectations of anxiety relief activate a generalized modulatory network","volume":"46","author":"Petrovic","year":"2005","journal-title":"Neuron"},{"issue":"1","key":"10.1002\/da.22673-BIB0028|da22673-cit-0028","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev.psych.59.113006.095941","article-title":"A comprehensive review of the placebo effect: Recent advances and current thought","volume":"59","author":"Price","year":"2008","journal-title":"Annual Review of Psychology"},{"issue":"3","key":"10.1002\/da.22673-BIB0029|da22673-cit-0029","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000209348","article-title":"Does study design influence outcome","volume":"78","author":"Rutherford","year":"2009","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"8","key":"10.1002\/da.22673-BIB0030|da22673-cit-0030","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0006-3223(00)00846-5","article-title":"Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression","volume":"47","author":"Schatzberg","year":"2000","journal-title":"Biological Psychiatry"},{"issue":"4","key":"10.1002\/da.22673-BIB0031|da22673-cit-0031","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ajog.2004.02.012","article-title":"Manipulation of the pill-free interval in oral contraceptive pill users: The effect on follicular suppression","volume":"190","author":"Schlaff","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"9","key":"10.1002\/da.22673-BIB0032|da22673-cit-0032","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1017\/S0033291716003524","article-title":"Predictors of premenstrual impairment among women undergoing prospective assessment for premenstrual dysphoric disorder: A cycle-level analysis","volume":"47","author":"Schmalenberger","year":"2017","journal-title":"Psychological Medicine"},{"issue":"4","key":"10.1002\/da.22673-BIB0033|da22673-cit-0033","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199801223380401","article-title":"Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome","volume":"338","author":"Schmidt","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/da.22673-BIB0035|da22673-cit-0035","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4088\/JCP.08r04516blu","article-title":"Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses","volume":"71","author":"Sinyor","year":"2010","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/da.22673-BIB0036|da22673-cit-0036","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0029-7844(96)00488-7","article-title":"Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms","volume":"89","author":"Sulak","year":"1997","journal-title":"Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/da.22673-BIB0037|da22673-cit-0037","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0015-0282(99)00205-8","article-title":"Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity","volume":"72","author":"Sullivan","year":"1999","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/da.22673-BIB0038|da22673-cit-0038","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","article-title":"Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder","volume":"106","author":"Yonkers","year":"2005","journal-title":"Obstetrics & Gynecology"},{"issue":"6","key":"10.1002\/da.22673-BIB0039|da22673-cit-0039","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1471-0528.2004.00135.x","article-title":"The effectiveness of GnRHa with and without \u2018add-back\u2019 therapy in treating premenstrual syndrome: A meta analysis","volume":"111","author":"Wyatt","year":"2004","journal-title":"BJOG: An International Journal of Obstetrics & Gynaecology"}],"container-title":["Depression and Anxiety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fda.22673","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/da.22673\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T13:04:48Z","timestamp":1671541488000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/da.22673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,17]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"URL":"https:\/\/doi.org\/10.1002\/da.22673","archive":["Portico"],"relation":{},"ISSN":["1091-4269"],"issn-type":[{"value":"1091-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7,17]]}}}